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Abstract The role of p53 in DNA repair and cell cycle
checkpoint after ultraviolet irradiation was investigated in an
embryonic stem cell line homozygous for a targeted deletion of
p53. Results indicate that loss of p53 does not alter the capacity
of ES cells to respond to DNA damage. Wild-type and p53-
deficient cells showed similar cessation of DNA synthesis after
UV damage and similar ultimate capacity to repair a transiently
transfected reporter plasmid. Interestingly, in the absence of
DNA damaging treatment, the transit of p53-deficient cells
through S phase was slower than wild-type cells. We suggest that
this may result from the absence of a p53-dependent response to
endogenous DNA damage: without p53 sensing endogenous
damage leading to immediate repair, such damage may persist
and thus delay DNA synthesis.
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1. Introduction
The cellular response to DNA damage includes activation
of DNA repair, cell cycle arrest and, in some situations, death
by apoptosis [1^3]. DNA damage can take many di¡erent
forms and rather little is known of the factors that permit
its recognition and coupling to these responses. There is how-
ever increasing evidence for involvement of a small set of
common regulatory molecules that include the onco-suppres-
sor protein p53. The precise responses regulated through p53
in cells sustaining DNA injury depend on the damage stim-
ulus [4,5], the cell type [6], and the di¡erentiation state but are
frequently associated with cell cycle checkpoints or initiation
of apoptosis. Whilst the consequences of p53 de¢ciency or
dysfunction for growth arrest and apoptosis in di¡erent tis-
sues are well described [5], the e¡ects of p53 on DNA repair
process are less certain. Early observations led to the hypoth-
esis that growth arrest provided time for completion of repair
prior to replication. More recent in vitro data have suggested
that p53 can directly regulate proteins involved in nucleotide
excision repair [7^9]. At present there remain con£icting data
from di¡erent systems about the role of p53 de¢ciency in
DNA repair [10^15].
The present study aimed to better de¢ne the consequences
of p53 de¢ciency for DNA repair by investigating the relation-
ship between p53 genotype, cell cycle activity and DNA repair
in mouse embryonic stem (ES) cells stimulated by genotoxic
injury (UV irradiation). Such cells are continuously prolifer-
ating but non-transformed and remain capable of contribu-
ting to embryogenesis. They thus represent a system in which
maintenance of genetic integrity and hence e⁄cient repair
should be critical, and a sensitive model to evaluate a role
for p53 in DNA repair. Moreover, as totipotential cells they
are free from modifying in£uences imposed by di¡erentiation
and thus provide a general paradigm for p53 and repair in
proliferating cells.
2. Materials and methods
2.1. Cell cycle analysis by £ow cytometry
All analyses were performed on exponentially growing ES cells
(passages 23 to 27 and 18 to 21 for wild-type and p53-null cells
respectively). For single parameter £ow cytometry analysis, cultures
were trypsinised, pelleted and nuclei prepared and stained by propi-
dium iodide as described by Vindelov [16]. The relative proportion of
cells in di¡erent phases of the cell cycle (average þ S.E.M.) were de-
termined from eight independent experiments.
For dual parameter £ow cytometry cells were cultured with BrdU
10 WM for 20 min and then, depending on experimental protocol,
either harvested immediately or washed 3 times and cultured for a
further chase period in BrdU-free fresh medium. After trypsinisation,
cells were ¢xed in ethanol and stored at 320‡C until use. Nuclei were
then prepared by pepsin digestion (20 min at 0.2 mg/ml in 2 M HCl)
and incorporated BrdU was labelled by a standard indirect immuno-
£uorescence technique. The primary antibody was monoclonal rat
anti-bromodeoxyuridine (Sera Labs) and the secondary antibody
FITC-conjugated Rabbit anti-Rat (Serotec) (both at 1/100 dilution
in PBS containing 0.5% Tween 20 and 5% normal serum). After
two ¢nal washes in PBS, nuclei were resuspended in 10 mg/ml of
ice cold propidium iodide solution containing 0.04% RNAse and an-
alysed for integral red and green £uorescence on a Coulter EPICS
£ow cytometer.
2.2. p53 reporter plasmid
Cells cultured for 24 h in 24 well plates were transfected independ-
ently with three di¡erent plasmids: pRGCvFosLacZ is a p53 reporter
plasmid containing two copies of the RCG p53-speci¢c binding site
upstream of a non-functional fos promoter and a lacZ gene; the
negative control plasmid pvFosLacZ is identical except lacking the
RGC p53 binding site [17]; the positive plasmid pCMVL (Clontech)
carries the LacZ gene under the control of a constitutive promoter.
Transfections were performed using Lipofectin (Gibco). Brie£y,
plasmid DNA (1 Wg) and Lipofectin (4 Wg), each diluted in serum-
free medium (200 and 100 Wl respectively), were incubated for 30 min
at room temperature. Plasmid and Lipofectin were then mixed and
further incubated for 45 min before laying the complex over the cells.
After 6 h of incubation at 37‡C in a CO2 incubator, the DNA-con-
taining medium was replaced by fresh medium containing 10% serum.
Forty-eight hours after transfection, cells were UV-C irradiated (10 J/
m2), cultured for further 3 to 24 h and then lysed in 100 Wl of Re-
porter Lysis Bu¡er (Promega). L-galactosidase activity was deter-
mined using ONPG substrate (Promega L-galactosidase enzyme as-
say), and expressed relative to the amount of protein (Biorad protein
assay) recovered from each well.
2.3. Reactivation of a UV-C irradiated reporter plasmid
The pOP13 CAT reporter plasmid (Stratagene) was treated with
UV-C at various doses and then cotransfected with unirradiated
pCMVL (1:1 ratio) into embryonic stem cell cultures (using Lipofectin
as described above). The cells were lysed in Reporter Lysis Bu¡er
(Promega) either 24 or 48 h after transfection.
The CAT activity in transfected cells was measured with Quan-T-
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CAT assay system (Amersham) used according to the manufacturer’s
instructions. This assay is based upon acetylation of biotylated chlor-
amphenicol with radiolabelled acetylCoA. This binds to streptavidin
coated polystyrene beads that are pelleted, washed and resuspended in
scintillation liquid.
The results for each lysate were corrected for the transfection e⁄-
ciency, as given by the L-galactosidase activity resulting from the
undamaged pCMVL expression (Promega assay) per Wg of protein
(Biorad protein assay). Reactivation of CAT activity from the irradi-
ated plasmid was calculated relative to the activity for an undamaged
plasmid.
3. Results
3.1. UV irradiation induces accumulation and increased
transcriptional activity of p53
The kinetics of p53 protein accumulation in wild-type ES
cells following UV-C irradiation were studied by immunocy-
tochemistry using the monoclonal antibody pAb 421 (Onco-
gene Science; 1/1000 dilution). Non-irradiated cultures
showed a low prevalence of weak nuclear p53 immunoposi-
tivity (less than 5% of cells). However, within 1 h after UV
treatment (10 J/m2, 254 nm) over 80% of cells had become
strongly immunopositive for p53 and the intensity of positive
staining continued to increase for 6 h. This response was
sustained until at least 10 h after irradiation (data not shown).
Changes in the transcriptional activity of p53 were also
studied, using a p53-speci¢c reporter plasmid (pRGCv-
FosLacZ) that was introduced into wild-type ES cells by
lipofection. UV-C irradiation of transfected cultures was
followed by an increase in reporter L-galactosidase activity
(1.8-fold) that peaked 9^12 h post treatment (Fig. 1A), whilst
control plasmid (pvFosLacZ) transfectants showed no signi¢-
cant activity throughout (Fig. 1B and data not shown). Inter-
estingly, LGal activity of unirradiated cells transfected with
the p53-speci¢c reporter plasmid was still approximately 3-
fold greater than cells transfected with the control p53 unre-
sponsive plasmid (0.39 mU/Wg of protein versus 0.14), indicat-
ing a signi¢cant baseline p53 transactivation activity in these
cells. This is in keeping with the signi¢cant level of p53 im-
munopositivity observed in the non-transfected cultures and
in agreement with the work from Sabapathy et al. [18] report-
ing that proliferating undi¡erentiated ES cells express a high
level of transcriptionally active p53. Taken together these re-
sults suggest physiological p53 activity in these actively divid-
ing cultures.
We considered the possibility that sensitivity of the reporter
plasmid assay might be reduced by general suppression of
transcription following UV treatment [19]. Therefore, parallel
cultures were transfected with plasmid constitutively express-
ing LacZ (pCMVL). A 25% decrease in constitutive LGal
activity was observed after UV treatment at the timepoint
when pRGCvFosLacZ activity was at peak (Fig. 1B), making
even more signi¢cant the observed increase in LGal activity in
pRGCvFosLacZ transfectants.
3.2. Repair of a UV-damaged plasmid is faster in p53-de¢cient
cells
DNA repair e⁄ciency in p53-null and wild-type ES cells
was evaluated using a host cell reactivation assay. A CAT
reporter plasmid, damaged in vitro, and a control LacZ-ex-
pressing plasmid, were transiently cotransfected in ES cells.
The CAT activity, 24 and 48 h after transfection re£ects the
DNA repair ability of the cells. Comparisons were made with
a control, undamaged CAT reporter plasmid and appropriate
corrections were made to take account of the transfection
e⁄ciency using the cotransfected undamaged LacZ plasmid.
In addition to functional assessment of e¡ective repair, these
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Fig. 1. p53 transactivation function after UV treatment (10 J/m2) as determined with a reporter plasmid. A: Time course after 10 J/m2 UV-C.
L-galactosidase activity is expressed relative to untreated transfected cells. B: L-galactosidase activity 9 h after 10 J/m2 UV-C (indicated by +)
and without UV (indicated by 3), for the p53 reporter plasmid (RGCvFosLacZ), the negative control plasmid (vFosLacZ) and the constitutive
pCMVL plasmid. Note that A and B are results of independent experiments.
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experiments avoid the e¡ects of whole cell UV irradiation,
and a more physiological assessment of cellular repair ca-
pacity can be made.
As expected, there was a UV dose-related impairment of
reporter function (Fig. 2). Twenty-four hours after transfec-
tion, p53-de¢cient cultures showed a signi¢cantly greater re-
covery of CAT reporter activity from plasmids damaged with
the lower doses of UV, relative to controls, than did wild-type
transfectants (Mann Whitney P = 0.0001 for 500 J/m2,
P = 0.0012 for 750 J/m2). Moreover, for these lower doses of
UV, there was no signi¢cant improvement in plasmid CAT
activity between 24 and 48 h, indicating maximal repair by
24 h. By contrast, wild-type transfectants at 24 h had recov-
ered only about 70% of the activity at 48 h. Taken together
these ¢ndings indicate that p53-de¢cient cells repair weakly
damaged plasmid more rapidly than wild-type, and this repair
is completed as far as possible within 24 h, although the
ultimate capacity to repair damage is similar between geno-
types.
3.3. Cell cycle analysis of wild-type and p53-null ES cells
3.3.1. Wild-type and p53-de¢cient cells have di¡erent cell
cycle distributions. DNA content and cell cycle analyses
were performed by £ow cytometry on exponentially growing
wild-type and p53-null ES cells at various passage numbers.
Despite similar doubling times for cultures of the two geno-
types (19 and 21 h for p53-null cells and wild-type, respec-
tively), cell cycle analysis on propidium iodide-stained cells
showed a smaller proportion of p53-null cells in G0/G1 phase
compared with wild-type cells (22.8 þ 1.7 and 35.5 þ 0.5% re-
spectively). Proportions of both S and G2/M phases in p53-
null cells were increased commensurately (50.3 þ 4.3 versus
43.6 þ 2.9 for S phase and 26.9 þ 2.9 versus 20.9 þ 3.3 for G2).
To better characterise these di¡erences BrdU pulse-chase
experiments were performed: unsynchronised cultures were
pulse-labelled with BrdU for 20 min and, after removal of
BrdU, were allowed to continue cycling for a chase period
of up to 8 h before harvesting for analysis by dual parameter
£ow cytometry (Fig. 3). One major ¢nding emerged: p53-de-
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Fig. 3. Cell cycle progression in wild-type and p53-null ES cells by
dual parameter £ow cytometry. Unlabelled and BrdU pulse-labelled
cell populations were followed for up to 8 h after a 20 min BrdU
pulse exposure. The ¢gure shows progression of the BrdU pulse-la-
belled cohort through S phase, increasing their DNA content with
time, and the entry of unlabelled cells into S phase during this chase
period (arrow). Note that progression of the labelled cohort through
S phase (from 2n to 4n) is more advanced for wild-type cells com-
pared with p53-null cells at the same timepoint, representing a faster
rate of replicative DNA synthesis.
Fig. 2. Reactivation of a CAT reporter plasmid. The CAT activities 48 h after transfection, corrected according to the transfection e⁄ciency, is
given relative to the activity of an untreated plasmid transfected under the same conditions. The ¢gure shows the average CAT activity from n
independent transfections þ S.E.M. from four independent experiments.
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¢cient cells showed slower transit from 2n to 4n DNA content,
indicating that S phase is longer than in wild-type (Fig. 3).
3.4. ES cells show p53-independent S phase arrest after DNA
damage
Following the demonstration of di¡erences in cell cycle
characteristics between p53 genotypes it was of interest to
study the e¡ects of DNA damage (UV irradiation) on the
cell cycle of wild-type and p53-de¢cient ES cells.
First, the e¡ect of UV on replicative DNA synthesis was
assessed by BrdU pulse labelling of cultures at various times
after UV irradiation (10 J/m2), and harvesting of cells at the
end of the 20 min pulse (Fig. 4). By 1 h after irradiation,
BrdU incorporation was reduced (decreased amplitude of
log green £uorescence of S phase cells) and by 6 h was nearly
completely abolished in both wild-type and p53-de¢cient cells
already in S phase, indicating cessation of replicative DNA
synthesis. By 9^12 h, the BrdU uptake began to recover to-
wards a normal level in both genotypes. These results there-
fore demonstrate a delayed, transient arrest in S phase after
UV irradiation that is independent of p53, and sustained for
3^6 h.
These experiments show a reduction of DNA synthesis after
UV irradiation, but do not inform about checkpoints in G1 or
G2/M. Therefore, a series of pulse-chase experiments were
performed on UV irradiated cells. When compared with un-
irradiated controls, UV-treated cultures of both genotypes
showed delay in the increase in DNA content of a BrdU
pulse-labelled population, labelled immediately after UV
treatment and followed for various chase intervals (Fig. 5).
This is consistent with the transient S phase arrest after UV
described above. Moreover, when DNA replication recom-
menced (9 h post irradiation), positive cells were also observed
with 2n DNA content (G1 phase), showing that at this time,
cells had traversed G2 and undergone mitosis. Furthermore,
the entry from G1 into S phase of unlabelled (9 h) and sub-
sequently the BrdU-positive cells (12 h) showed also that there
was no signi¢cant G1 arrest at that time (Fig. 5).
4. Discussion
p53 function has been investigated in numerous cell sys-
tems, but comparison of results is confounded by variability
of cell type, di¡erentiation and transformation status (re-
viewed in [5]). Embryonic stem cells are pluripotent, perma-
nent cells, capable of contributing to normal embryogenesis,
and were therefore thought to be a good model to study the
consequences of p53 de¢ciency for cell cycle and DNA repair,
independently of ill-de¢ned transformation or di¡erentiation
parameters.
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Fig. 4. E¡ect of UV irradiation on replicative DNA synthesis in wild-type and p53-de¢cient ES cells. Cells irradiated or not (controls) with
UV-C (10 J/m2) were then incubated for 20 min with BrdU at various timepoints, then harvested immediately and analysed by dual parameter
£ow cytometry. BrdU uptake is depicted as two-parameter (upper) and single parameter (lower) histograms for both genotypes.
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Surprisingly, UV treatment su⁄cient to stabilise and acti-
vate p53 did not produce any di¡erence between genotypes in
either cell cycle or repair responses. The only detectable e¡ect
on cell cycle in UV-treated ES cells was a p53-independent
inhibition of DNA replication. The failure to detect a p53-
dependent G1 cycle arrest after DNA damage in these cells is
perhaps not surprising since ES cells were found to have a low
proportion of cells in G1. p53 acts in G1 by blocking the entry
to S phase [20], but once the cells are in S phase p53 has no
more e¡ect on their cell cycle regulation [20]. The high pro-
portion of ES cells in S phase and their short G1 phase [21]
therefore render them more likely to be hit in S phase. More-
over, it was recently reported that ES cells that express high
level of functionally active p53 retain the capacity to prolifer-
ate rapidly and have a very short G1 phase [18]. The authors
suggested that the cell cycle regulation in embryonic stem cells
could have evolved to tolerate high level of p53 expression
[18].
The observation that cessation of replicative DNA synthesis
after UV is p53-independent is in agreement with previous
¢ndings in bleomycin-treated ¢broblasts [22]. The arrest is
only apparent from 3 h after UV irradiation, suggesting that
inhibition of DNA synthesis is not simply due to mechanical
blockade of the replication fork by UV-induced pyrimidine
dimers, but more probably from a second event that could
be the appearance of DNA breaks during nucleotide excision
repair. This inhibition of DNA synthesis (reviewed in [3]) has
a clear checkpoint quality since it occurs at low doses, is
maximal during the time of active DNA repair and resolves
as repair subsides leading to the recovery of the normal level
of DNA synthesis. There is common perception that the S
phase checkpoint is equivalent to the G1 checkpoint because
both responses delay or inhibit the initiation of DNA syn-
thesis. However, the inhibition of replicon initiation occurs
in S phase and must utilise biochemical signals that are di¡er-
ent from those that cause G1 arrest. Results from Orren et al.
[23] demonstrated that persistent UV-produced DNA damage,
and not activation of signal transduction pathways resulting
from general cell stress, is the cause of prolonged delays in the
S phase progression. They also demonstrated that the DNA
repair ability of the cells is directly related to the alteration of
the S phase progression and extended cell cycle arrest. In
agreement with this ¢nding, we found that wild-type and
p53-null ES cells exhibited both similar delays in S phase
progression and ultimate DNA repair capacity. As expected
by these results, mutation frequency after UV irradiation was
increased to a similar level in wild-type and p53-null ES cells
(Corbet et al., personal communication). To that extent there-
fore, repair in DNA-damaged ES cells can be considered p53-
independent, in accord with results of Ishizaki [14] for photo-
product removal in UV irradiated wild-type and p53-null
mouse embryo ¢broblasts. In contrast to our ¢nding, others
have suggested that p53 does regulate NER of UV-induced
DNA damage [10^13,24]. However, those studies di¡ered
from the present in design, utilising mutant p53 [10,11,13]
or E6 overexpression [12], which in themselves present con-
founding factors to comparison with the present results and
those of Ishizaki [14] for p53 de¢ciency: for example, possible
gain of function of mutant p53 [25^27], interaction of the
mutated p53 with the wild-type allele [11] and interaction of
E6 with other proteins [28,29].
The ¢ndings that untreated p53-null ES cells exhibit a slow-
er S phase than wild-type and that the repair of the damaged
plasmid is faster for the lower doses of damage is rather
interesting. It is possible that this reduced DNA synthesis
re£ects a response to endogenous DNA damages. DNA
strand breaks occur during normal replication and may be
induced by spontaneously produced free radicals. If p53 is
normally involved in sensing [30^34] and signalling these types
of injury then the absence of p53 might lead to persistence of
endogenous DNA damage with compensatory S phase delay.
The increased basal level of DNA repair could be an artifact
re£ecting the di¡erences in the proportion of cells in G1 and S
phase of the cell cycle. This would explain the faster recovery
of CAT activity when the reporter plasmid carries only a low
level of damage but an ultimate DNA repair capacity similar
to that of wild-type ES cells. Slower replicative DNA synthe-
sis has not previously been reported as a feature of p53-de¢-
cient cells, however Ishizaki et al. described an increased S
phase fraction in p53-de¢cient cells [14], which although as-
cribed to the loss of a p53-dependent G1 checkpoint, could
have been due to a prolonged S phase as observed here. In
their study, the cells themselves were UV irradiated preventing
the observation of a possible increase in basal DNA repair.
In summary, in normal undamaged proliferating ES cells,
p53 is expressed and transcriptionally active (this study, [18]).
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Fig. 5. Dual parameter £ow cytometric cell cycle analysis in wild-
type ES cells after UV irradiation. Unsynchronised wild-type cul-
tures were pulse exposed to BrdU for 20 min just after UV irradia-
tion, to label cells in S phase. BrdU was removed and cultures were
harvested after various chase intervals, of which four are depicted.
Unirradiated controls show the BrdU-positive cohort increasing its
DNA content with time, and the appearance of BrdU-positive cells
in G1 (2n DNA content). By contrast UV-treated cultures show sim-
ilar but delayed changes (compare arrows), indicating a delayed
transient S phase arrest, terminating by 9 h post treatment.
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After DNA damage, p53 has no e¡ect on the regulation of cell
cycle checkpoints and no e¡ect on the ultimate DNA repair
capacity of ES cells. However, after high levels of DNA dam-
age, these cells do undergo p53-dependent apoptosis (data not
shown and Corbet et al., personal communication). More
interestingly, the present work demonstrates that p53 may
have a role in sensing basal levels of endogenous DNA dam-
age, and that in the absence of p53, a compensatory increase
in DNA repair can occur. There is an important prediction
arising from this model: p53-de¢cient cells will repair DNA
damage without acquiring potentially damaging mutations.
This is consistent with results showing no e¡ect of p53 de¢-
ciency on the incidence of point mutations [27,35^37]. A fur-
ther prediction of the model is that the compensatory mech-
anisms might be e¡ective on most occasions, but mutations
occurring are likely to be qualitatively di¡erent to those of
wild-type cells. Intriguingly, Ishizaki et al. have recently
shown that p53-de¢cient cells do indeed accumulate di¡erent
types of mutation to wild-type [35]. Taken together, these data
indicate that p53 is important to provide the most e⁄cient
balance between DNA repair and replication under normal
conditions. They are additional evidence for an active cou-
pling between these fundamental cellular processes.
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